Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1, Mouse, Clone: 1F1, Abnova™

Mouse monoclonal antibody raised against a partial recombinant C1GALT1.

Supplier:  Abnova Corporation H00056913M01

Catalog No. 89-014-322


Only null left
Add to Cart

Description

Description

The common core 1 O-glycan structure Gal-beta-1-3GalNAc-R is a precursor for many extended mucin-type O-glycan structures in animal cell surface and secreted glycoproteins. Core 1 is synthesized by the transfer of Gal from UDP-Gal to GalNAc-alpha-1-R by core 1 beta-3-galactosyltransferase (C1GALT1) (Ju et al., 2002 [PubMed 11677243]).[supplied by OMIM

Sequence: ETFHPFVPEHHLIKGYLPRTFWYWNYNYYPPVEGPGCCSDLAVSFHYVDSTTMYELEYLVYHLRPYGYLYRYQPTLPERILKEISQANKNEDTKVKLGNP
Specifications

Specifications

core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1
Monoclonal
Unconjugated
PBS with no preservative; pH 7.4
NM_020156
C1GALT1
C1GALT1 (NP_064541, 264 a.a. ∼ 363 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
100 μg
Angiogenesis
56913
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
IgG2a κ
ELISA, Immunohistochemistry (PFA fixed), Western Blot
1F1
Mouse monoclonal antibody raised against a partial recombinant C1GALT1.
C1GALT1
C1GALT/T-synthase
Mouse
Affinity Purified
RUO
Primary
Human
Antibody
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.